2021 | Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study | Huang, Huiqiang; Zhu, Jun; MING YAO ; Kim, Tae Min; Yoon, Dok Hyun; Cho, Seok-Goo; Eom, Hyeon Seok; Lim, Soon Thye; Yeh, Su-Peng; Song, Yuqin; Kwong, Yok Lam; Kim, Jin Seok; Jin, Jie; Shi, Yuankai; Kim, HyeJin; Qing, Min; Zhou, Tianyuan; Gao, Grace; Dong, Zongqi; Qi, Ming; Kim, Won Seog | Journal of hematology & oncology | 37 | 37 | |
2024 | Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab | Qing, Min; Zhou, Tianyuan; Perova, Tatiana; Abraham, Yann; Sweeney, Cheryl; Krevvata, Maria; Zhang, Xiaokang; Qi, Ming; Gao, Grace; Kim, Tae Min; MING YAO ; Cho, Seok-Goo; Eom, Hyeon Seok; Lim, Soon Thye; Yeh, Su-Peng; Kwong, Yok Lam; Yoon, Dok Hyun; Kim, Jin Seok; Kim, Won Seog; Zhou, Longen; Attar, Ricardo; Verona, Raluca I | Annals of hematology | | | |